Carlo J Iasella

5PUBLICATIONS
9CO-AUTHORS
Intensive careInnate immunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 24, 2024
Impact of variable titer COVID-19 convalescent plasma and recipient SARS-CoV2-specific humoral immunity on survival in hospitalized patients.

Carlo J Iasella, Stefanie J Hannan, Emily J Lyons

|Aug 25, 2021
Rate of recipient-derived alveolar macrophage development and major histocompatibility complex cross-decoration after lung transplantation in humans.

Mark E Snyder, Anna Bondonese, Andrew Craig

|Oct 20, 2020
Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction.

Carlo J Iasella, Aki Hoji, Iulia Popescu

|Jan 23, 2020
Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism.

James C Coons, Lauren Albert, Andrea Bejjani

|Dec 25, 2019
Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival.

Carlo J Iasella, Spencer A Winters, Abigail Kois

Pageof 1

Frequent Collaborators

2 joint publications

John F McDyer

2 joint publications

Mark E Snyder

1 joint publications

James C Coons

1 joint publications

Monica Fung